Boston Scientific Corporation has alerted the public about a stolen shipment of medical devices for endoscopy and urology/women’s health.
Boston Scientific Corporation has alerted the public about a stolen shipment of medical devices for endoscopy and urology/women’s health. These devices were stolen while en route to the company’s sterilization facility. Although the devices are labeled “sterile,” they are nonsterile, and use of these devices can cause infection. A list of specific devices involved can be obtained at http://www.fda.gov/ICECI/CriminalInvestigations/ucm253675.htm. All patients who have been or may have been treated with these stolen devices should be monitored and treated for adverse events, such as post-operative infection.
Reference
1. U. S. Food and Drug Administration. Boston Scientific devices stolen â risk of infection. Available at:http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm253937.htm. Accessed May 15, 2011.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More